GlenRock Israel

www.grg.co.il

Investment Company

Tech Verticals Preferences

AgriBiotech, Automotive, Bioinformatics, Biotechnology, Cyber Security, Digital Media, EDA, Enterprise Applications, Hardware, Industrial Technologies, Internet Infrastructure, Life Sciences, Manufacturing & Equipment, Medical Devices, MedTech, Mobile Applications, Networking Infrastructure, Security, Semiconductors, Software Technologies, Wireless Applications

General Data

Established	2003
Current Active Portfolio Companies:	35
Reg. Number:	abCDe

DESCRIPTION

GlenRock Israel is a single family office leveraging a unique combination of private equity funding agility, multidisciplinary in-house expertise, unmatched access to quality deal flow and a focused but flexible investment strategy to achieve maximum returns. With an access to a global network and the most prominent names in Israeli business, academia and science, GlenRock is experienced at identifying Life Sciences and advanced technology opportunities.

REMARKS

Date	Remark
	Glenrock's investments in companies founded by Yossi Gross are organized under Rainbow Medical.

CONTACT INFO

Expand / Collapse All

Main Address: Herzliya, Israel

Address	85 Medinat Hayehudim St., Tower G, 8th Floor, Business Park
POB	4031
City	Herzliya
Country	Israel
Zip	4676670

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Leon Recanati	Founder, Chairman & CEO
Mr. Asaf Iram	Managing Partner
Ms. Ronit Izraeli	CFO

	FINANCIAL ROUNDS

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Investment in Fund

Jan. 01, 2003

abCDe

Investment Data

Preferences

Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Enterprise Software & Infrastructure

30%

Medical Devices

22%

Hardware & Industrial

Biomed

Consumer-Oriented Software

Digital Health

Agritech

Energy

Network Infrastructure

Semiconductors

	PORTFOLIO COMPANIES

Current Portfolio Companies (35)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

270Surgical

Second Round	15/06/2020	N/A	N/A
First Round	01/11/2018	N/A	$13.5m

BrainsGate

Fifth Round	25/01/2015	N/A	$26m
Fourth Round	11/08/2011	N/A	$20m
Third Round	13/08/2008	N/A	$27.5m
Second Round	11/04/2005	N/A	$10m

Cellium

Network Infra.

Second Round	01/05/2021	N/A	$1.83m
First Round	21/10/2020	N/A	N/A
Seed	01/12/2018	N/A	$2m

Classiq

Ent. SW

Second Round - Extended

16/05/2022

N/A

$15m

Constru.ai

Constru is an AI-powered construction solution that turns captured imagery into insights for better data-driven decision making. Constru drives efficiency on projects by providing teams the ability to get first-hand, image-based data, process it for insight, and see it in context mapped to project plans.

Ent. SW

First Round - Extended

28/09/2022

N/A

$8m

CrediArc

Ent. SW

Seed

01/03/2023

N/A

$0.5m

Cylus

Ent. SW

Second Round - Extended	15/12/2021	N/A	$30m
First Round	06/06/2019	N/A	$12m

Elgan Pharma

Biomed

First Round

24/11/2022

N/A

$4m

Exelot

Ent. SW

Seed

01/07/2016

N/A

$2m

Gigamedia

N/A

Other

N/A

Home365

CO SW

Second Round

29/03/2022

N/A

$26m

Homelend

Ent. SW

First Round

10/05/2024

N/A

$10.2m

iCard Technologies Ltd. (not an Israeli company)

N/A

First Round

01/10/2004

N/A

Karamba

Ent. SW

Second Round - Extended	02/12/2021	N/A	$10m
Second Round	16/05/2017	N/A	$12m
First Round	29/09/2016	N/A	$2.5m
Seed	07/04/2016	N/A	$2.5m

Lydus

Biomed

Seed - Extended

01/08/2021

N/A

$2.7m

Magnus Metal

HW & Indust.

Second Round	21/09/2023	N/A	$55m
First Round - Extended	17/01/2021	N/A	$5m

Mivtach Shamir

N/A

Other

N/A

MSICS Pharma

Biomed

Seed - Extended

01/06/2024

N/A

Nonagon

Dig. Health

First Round	09/02/2022	N/A	N/A
Seed - Extended	01/10/2020	N/A	N/A

Nurami Medical

Nurami's proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. It addresses complications associated with current soft tissue implants, such as dangerous leaks, and promotes healthy tissue formation, such as Dura repair, as well as other tissue recovery processes.

Fourth Round	04/03/2025	N/A	$30m
Third Round - Extended	01/01/2024	N/A	$6m
Third Round	31/10/2020	N/A	$6m

Perfect

Ent. SW

Seed

20/12/2022

N/A

$12m

PV Nano Cell

HW & Indust.

Second Round

11/12/2014

N/A

$1.3m

Quantum Machines

HW & Indust.

Second Round

08/09/2021

N/A

$50m

Quris

Dig. Health

Seed - Extended	30/07/2023	N/A	N/A
Seed - Extended	20/12/2022	N/A	$9m
Seed - Extended	30/12/2021	N/A	$19m

Rainbow Medical

N/A

Investment in Fund	03/06/2012	N/A	$50m
Investment in Fund	01/01/2007	N/A	N/A

RoutePerfect

CO SW

Second Round	16/12/2016	N/A	$2m
First Round	01/06/2015	N/A	$1.4m

Scopio

Fourth Round

25/07/2024

N/A

$42m

Smart Medical Systems

Second Round

15/02/2018

N/A

$8m

Stargo

Ent. SW

Third Round

28/04/2021

N/A

$6.5m

StoreDot

Energy

Fourth Round	04/01/2022	N/A	$70m
Third Round	09/08/2017	N/A	$60m
Second Round	01/10/2014	N/A	$42m
First Round	25/06/2013	N/A	$6m

Syqe Medical

Second Round

31/12/2018

N/A

$50m

Treetoscope

Agri

Seed - Extended

01/08/2023

N/A

$7m

Voll

Seed

28/07/2024

N/A

Worthy

CO SW

Fourth Round	03/10/2023	N/A	$25.3m
Third Round	01/04/2019	N/A	$28.8m
Second Round	22/10/2015	N/A	$8m

Xinteza

Agri

First Round - Extended

16/02/2021

N/A

Current VC Fund Portfolio (8)

Fund Name

Fund Type

Date Announced

Amount

Remarks

Infinity I-China

Venture Capital Fund

01/01/2006

N/A

Shavit Capital II

Venture Capital Fund

01/08/2013

N/A

Shavit Capital III

Venture Capital Fund

06/05/2015

N/A

Shavit Capital IV

Venture Capital Fund

01/06/2017

N/A

SOMV Momentum

Venture Capital Fund

24/08/2021

N/A

State of Mind...

Venture Capital Fund

29/01/2015

N/A

State of Mind...

Venture Capital Fund

22/01/2018

N/A

State of Mind...

Venture Capital Fund

01/08/2021

N/A

Exits (46)

Company Name		Exit Type	Date Announced	Amount	Remarks
abC Defghij		Acquired	05/06/2025	abCDe
abC Defghij		Acquired	20/08/2025	abCDe	Acquired the company's assets and technology.
abC Defghij		Acquired	08/12/2021	abCDe	$200m in cash while the rest will be given pending FDA approval.
abC Defghij		Acquired	01/01/2014	abCDe
abC Defghij		Acquired	10/11/2009	abCDe	Stock swap.
abC Defghij		Acquired	29/07/2025	abCDe	Cipia Vision sold its automotive technology & IP to Harman Becker Automotive Systems (Part of Harman International, a subsidiary of Samsung Electronics).
abC Defghij		IPO	23/11/2021	abCDe	Raised NIS 68m; Valuation NIS 354m
abC Defghij		Acquired	03/09/2007	abCDe
abC Defghij		Holdings Sold		abCDe
abC Defghij		Acquired	27/06/2022	abCDe
abC Defghij		Acquired	22/06/2020	abCDe
abC Defghij		Acquired	22/03/2017	abCDe
abC Defghij		IPO	24/11/2020	abCDe	Raised NIS 282.7m in share and options. If all options will be realized, additional NIS 157m would be raised.
abC Defghij		Acquired	11/01/2018	abCDe
abC Defghij		IPO	29/09/2013	abCDe
abC Defghij		IPO	14/05/2025	abCDe	Shareholders of eToro sold shares for additional $310m ($713m in total). Selling shareholders include BRM, Yoni Assia, Ronen Assia and company employees. Of the $403m raised by the company, $93m were as a result of the underwriters’ exercise of the over-allotment option (green shoe option) in full.
abC Defghij		IPO	12/06/2007	abCDe
abC Defghij		Acquired	01/03/2021	abCDe
abC Defghij		IPO	07/06/2021	abCDe	Raised NIS 75m; Post Valuation NIS 344m
abC Defghij		IPO	21/08/2005	abCDe
abC Defghij		Acquired	10/12/2019	abCDe
abC Defghij		Acquired	01/03/2018	abCDe	Google acquired all of LucidLogix's patents
abC Defghij (Incubator)		Holdings Sold		abCDe
abC Defghij		Acquired	23/05/2006	abCDe	Acquisition in trenches; Will end by 2008
abC Defghij		Acquired	24/06/2013	abCDe
abC Defghij		IPO	10/06/2007	abCDe
abC Defghij		Acquired	08/08/2017	abCDe
abC Defghij		IPO	01/08/2014	abCDe	Including Green Shoe Option ($132m).
abC Defghij		Acquired	27/04/2023	abCDe
abC Defghij		Acquired	02/03/2005	abCDe	In cash.
abC Defghij	$Neovasc developed and patented unique devices that are implanted within the Coronary Sinus. Neovasc wishes to enrol strong biotech pharma partners in order to develop a novel treatment modalities using a unique delivery system which will be located in the coronary sinus and thorough which therapeutic substances (stem cells, angiogenic drugs, growth factors, cytokines, and gene therapies) may be delivered to ischemic and infracted territories of the heart.$	Merged	01/07/2008	abCDe	In a share swap
abC Defghij		Acquired	17/06/2007	abCDe	$28m in cash
abC Defghij		Acquired	11/06/2017	abCDe
abC Defghij		Holdings Sold		abCDe
abC Defghij		Merged	16/04/2012	abCDe	An all-stock transaction with a combined equity value of $1.4B (Objet's derived value = $634m). The combined company will operate under the name Stratasys Ltd.
abC Defghij		IPO	08/03/2021	abCDe	Raised NIS 50m, Valuation NIS 222m
abC Defghij		Acquired	05/02/2012	abCDe	After Power Paper went into Chapter 11 bankruptcy .
abC Defghij		Acquired	04/11/2007	abCDe
abC Defghij		IPO	27/02/2007	abCDe	Including Green Shoe option ($3.7m)
abC Defghij		Acquired	01/11/2005	abCDe	Sold all its assets except holdings in several high-tech companies which will be devided by investors
abC Defghij		IPO	22/07/2021	abCDe
abC Defghij		Acquired	23/01/2017	abCDe	In stock & cash for Valtech at closing, subject to typical adjustments. In addition, there is the potential for up to $350m in pre-specified milestone-driven payments over the next 10 years.
abC Defghij		Acquired	16/10/2023	abCDe	A share swap deal. Notable stockholders now own approximately 75% and VBL shareholders own approximately 25% of the combined company. The merged company transitions into the Notable business. VBL remaining assets will be developed by a newly formed private company, Immunewalk Therapeutics.
abC Defghij		IPO	06/10/2014	abCDe
abC Defghij		IPO	30/11/2020	abCDe	Raised NIS 223m from institutional investors (NIS 218m) and the public (NIS5m)
abC Defghij		Acquired	10/04/2018	abCDe	An upfront payment of $40m, and then $25m according to milestones. An additional $10m is a possibility if certain unspecified milestones are met.

Historic Portfolio (20)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

AcadeMe+

Ceased to Operate

Ent. SW

Seed - Extended

01/04/2022

N/A

$0.75m

BetaStim

Ceased to Operate

Seed

01/10/2006

N/A

BioControl

Ceased to Operate

Fourth Round

01/06/2005

N/A

$3.75m

ChondroSite

Ceased to Operate

Biomed

Seed - Extended

01/10/2005

N/A

DTL

Suspendeed Operations

Biomed

First Round

20/08/2002

N/A

$2.5m

DuoCure

Ceased to Operate

Seed

01/10/2006

N/A

EarlySense

Ceased to Operate

Dig. Health

Seventh Round

01/09/2018

N/A

$39m

Endopix

Ceased to Operate

Dig. Health

Seed

01/04/2007

N/A

E-Pill

Ceased to Operate

Biomed

First Round

01/08/2005

N/A

$7m

FIMI I

N/A

Investment in Fund

01/01/1996

N/A

$150m

hipix

Ceased to Operate

Ent. SW

Second Round	01/11/2010	N/A	N/A
First Round	18/11/2007	N/A	$1m

Jetcu

Ceased to Operate

Cln.

Seed

01/06/2014

N/A

$2.1m

Mempile

Ceased to Operate

HW & Indust.

Third Round

15/11/2005

N/A

$10.5m

Microheat

Ceased to Operate

HW & Indust.

Fourth Round	20/04/2006	N/A	$15.1m
Third Round	01/12/2004	N/A	$14m

MoniTel

Ceased to Operate

Network Infra.

First Round

01/10/2005

N/A

PowerID

Ceased to Operate

Network Infra.

First Round

04/09/2007

N/A

$12m

Roei

Ceased to Operate

First Round

01/10/2004

$0.8m

ROX

Ceased to Operate

Ent. SW

First Round

01/06/2019

N/A

$10m

Shavit Capital I

N/A

Investment in Fund

01/07/2007

N/A

$30m

SOS Color

Ceased to Operate

Biomed

Seed

01/10/2005

N/A

Last Updated:	abCDe
IVC Number:	abCDe